Search Within

David R Spriggs

  1. "Early Drug Development Service"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (28)
  2. Early Drug Development Service (28)
  3. Solid Tumor Oncology Division (28)
  4. Epidemiology and Biostatistics (21)
  5. Biostatistics Service (20)
  6. GDMT, Medicine (17)

More Groups

People
  1. David Hyman (28)
  2. Alexia Iasonos (19)
  3. Rachel Grisham (15)
  4. Carol Aghajanian (12)
  5. Mrinal Gounder (9)
  6. Anne Eaton (8)

More People

Years
  1. 2018 (3)
  2. 2017 (2)
  3. 2016 (3)
  4. 2015 (7)
  5. 2014 (3)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (4)
  3. Cancer (3)
  4. Gynecologic Oncology (2)
  5. Annals of Oncology (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (4)
  3. Wiley Blackwell (3)
  4. Elsevier Inc. (2)
  5. Springer (2)
  6. American Medical Association (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials
    Journal Article

    Yokota, T.; Bendell, J.; Lorusso, P.; Tsushima, T.; Desai, V.; Kenmotsu, H.; Watanabe, J.; Ono, A.; Murugesan, B.; Silva, J.; more...
    British Journal of Cancer (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program
    Journal Article

    Drilon, A.; Eaton, A. A.; Schindler, K.; Gounder, M. M.; Spriggs, D. R.; Harris, P.; Ivy, S. P.; Iasonos, A.; Lacouture, M. E.; Hyman, D. M.
    Cancer (2016)

    Fulltext@MSK | Save
  • Measuring toxicity in phase I clinical trials-letter — Letter
    Journal Article

    Hyman, D. M.; Eaton, A.; Ivy, S. P.; Spriggs, D. R.; Iasonos, A.
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Toxicity attribution in phase I trials: Evaluating the effect of dose on the frequency of related and unrelated toxicities
    Journal Article

    Eaton, A.; Iasonos, A.; Gounder, M. M.; Pamer, E. G.; Drilon, A.; Vulih, D.; Smith, G. L.; Ivy, S. P.; Spriggs, D. R.; Hyman, D. M.
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save